Anti-KLK9/ KLK-L3/ KLKL3 functional antibody

Anti-KLK9/ KLK-L3/ KLKL3 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to KLK9/KLK9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1052-Ab-1/ GM-Tg-hg-SE1052-Ab-2Anti-Human KLK9 monoclonal antibodyHuman
GM-Tg-rg-SE1052-Ab-1/ GM-Tg-rg-SE1052-Ab-2Anti-Rat KLK9 monoclonal antibodyRat
GM-Tg-mg-SE1052-Ab-1/ GM-Tg-mg-SE1052-Ab-2Anti-Mouse KLK9 monoclonal antibodyMouse
GM-Tg-cynog-SE1052-Ab-1/ GM-Tg-cynog-SE1052-Ab-2Anti-Cynomolgus/ Rhesus macaque KLK9 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1052-Ab-1/ GM-Tg-felg-SE1052-Ab-2Anti-Feline KLK9 monoclonal antibodyFeline
GM-Tg-cang-SE1052-Ab-1/ GM-Tg-cang-SE1052-Ab-2Anti-Canine KLK9 monoclonal antibodyCanine
GM-Tg-bovg-SE1052-Ab-1/ GM-Tg-bovg-SE1052-Ab-2Anti-Bovine KLK9 monoclonal antibodyBovine
GM-Tg-equg-SE1052-Ab-1/ GM-Tg-equg-SE1052-Ab-2Anti-Equine KLK9 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1052-Ab-1/ GM-Tg-hg-SE1052-Ab-2; GM-Tg-rg-SE1052-Ab-1/ GM-Tg-rg-SE1052-Ab-2;
GM-Tg-mg-SE1052-Ab-1/ GM-Tg-mg-SE1052-Ab-2; GM-Tg-cynog-SE1052-Ab-1/ GM-Tg-cynog-SE1052-Ab-2;
GM-Tg-felg-SE1052-Ab-1/ GM-Tg-felg-SE1052-Ab-2; GM-Tg-cang-SE1052-Ab-1/ GM-Tg-cang-SE1052-Ab-2;
GM-Tg-bovg-SE1052-Ab-1/ GM-Tg-bovg-SE1052-Ab-2; GM-Tg-equg-SE1052-Ab-1/ GM-Tg-equg-SE1052-Ab-2
Products NameAnti-KLK9 monoclonal antibody
Formatmab
Target NameKLK9
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-KLK9 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1052-Ag-1Recombinant multi-species KLK9/ KLK-L3/ KLKL3 protein


    Target information

    Target IDGM-SE1052
    Target NameKLK9
    Gene ID284366,101533,292851,100424925,100329125,101097689,530795,100067196
    Gene Symbol and Synonyms1200016C12Rik,KLK-L3,KLK9,KLKL3,Klnf
    Uniprot AccessionQ9UKQ9
    Uniprot Entry NameKLK9_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000213022
    Target ClassificationN/A

    The target: KLK9, gene name: KLK9, also named as KLK-L3, KLKL3. The protein encoded by this gene is a kallikrein-related serine protease. This gene is activated by steroid hormones in a human breast cancer cell line, making it a good marker for cancer detection. The encoded protein is found primarily in the cytoplasm.[provided by RefSeq, Oct 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.